Plasma Epstein-Barr viral DNA complements TNM classification of nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy

BACKGROUND: The objective of this study is to verify the prognostic value of pretreatment plasma Epstein-Barr viral deoxyribonucleic acid (pEBV DNA) levels in nasopharyngeal carcinoma (NPC) patients to complement TNM classification based on the application of the intensity-modulated radiotherapy (IM...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lu, Tang, Lin-Quan, Chen, Qiu-Yan, Liu, Huai, Guo, Shan-Shan, Liu, Li-Ting, Guo, Ling, Mo, Hao-Yuan, Zhao, Chong, Guo, Xiang, Cao, Ka-Jia, Qian, Chao-Nan, Zeng, Mu-Sheng, Shao, Jian-Yong, Sun, Ying, Ma, Jun, Hong, Ming-Huang, Mai, Hai-Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868751/
https://www.ncbi.nlm.nih.gov/pubmed/26716900
http://dx.doi.org/10.18632/oncotarget.6754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868751/
https://www.ncbi.nlm.nih.gov/pubmed/26716900
http://dx.doi.org/10.18632/oncotarget.6754

Ejemplares similares